BridgeBio Pharma Stock News & Updates

[WKN: A2PLX7 | Symbol: BBIO]

Analysts' Top 5 Price Targets of September 1, 2025

Teamviewer [DE000A2YN900] Bank of America upgrades rating from Underperform to Buy and raises...

BridgeBio in Focus: Diversification as a Recipe for Success in the Fight Against Genetic Defects

BridgeBio Pharma is a biotechnology company focused on the discovery, development, testing, and provision...

Analysts' Top 5 Price Targets of July 14, 2025

Harrow Inc. [US4158581094] Cantor Fitzgerald starts coverage with Overweight and a price target of...

Analysts' Top 5 Price Targets of April 15, 2025

Puma [DE0006969603]: Berenberg initiates coverage with a Buy rating and a price target of €40 (100%...

BridgeBio Pharma is a Biotech Stock With Strong Potential Thanks to an Innovative Approach in Precision Medicine. Redburn Atlantic Sees Over 40% Upside Potential.

The biotech stock of BridgeBio Pharma (BBIO) has held up remarkably well in recent weeks. BridgeBio...

BridgeBio Pharma: Unrivaled Heart Medication Generates Record Revenues

Genetic disorders are generally considered rare diseases, but when they do occur, they are usually associated...

  • 1